EUVIMEDEUVIMED entdecken
Crossref

Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation

Basile Tessier-Cloutier, Felix K F Kommoss, David L Kolin, Kristýna Němejcová, DuPreez Smith, Jennifer Pors, Colin J R Stewart, W Glenn McCluggage, William D Foulkes, Andreas von Deimling, Martin Köbel, Cheng-Han Lee

Modern Pathology · 2024-01 · 37 (1) · 100374

DOI: 10.1016/j.modpat.2023.100374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-01. Verfasst von Basile Tessier-Cloutier und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Carcinoma, Endometrial Neoplasms, Carcinoma, Small Cell. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: WCHRI, Alberta Cancer Foundation, Children's Health Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dedifferentiated and undifferentiated ovarian carcinomas (DDOC/UDOC) are rare neoplasms defined by the presence of an undifferentiated carcinoma. In this study, we detailed the clinical, pathological, immunohistochemical, and molecular features of a series of DDOC/UDOC. We collected a multi-institutional cohort of 23 DDOC/UDOC and performed immunohistochemistry for core switch/sucrose nonfermentable (SWI/SNF) complex proteins (ARID1A, ARID1B, SMARCA4, and SMARCB1), mismatch repair (MMR) proteins, and p53. Array-based genome-wide DNA methylation and copy number variation analyses were performed on a subset of cases with comparison made to a previously reported cohort of undifferentiated endometrial carcinoma (UDEC), small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), and tubo-ovarian high-grade serous carcinoma (HGSC). The age of all 23 patients with DDOC/UDOC ranged between 22 and 71 years (with an average age of 50 years), and a majority of them presented with extraovarian disease (16/23). Clinical follow-up was available for 19 patients. Except for 2 patients, the remaining 17 patients died from disease, with rapid disease progression resulting in mortality within a year in stage II-IV settings (median disease-specific survival of 3 months). Eighteen of 22 cases with interpretable immunohistochemistry results showed loss of expression of core SWI/SNF protein(s) that are expected to result in SWI/SNF complex inactivation as 10 exhibited coloss of ARID1A and ARID1B, 7 loss of SMARCA4, and 1 loss of SMARCB1. Six of 23 cases were MMR-deficient. Two of 20 cases exhibited mutation-type p53 immunoreactivity. Methylation profiles showed coclustering of DDOC/UDOC with UDEC, which collectively were distinct from SCCOHT and HGSC. However, DDOC/UDOC showed an intermediate degree of copy number variation, which was slightly greater, compared with SCCOHT but much less compared with HGSC. Overall, DDOC/UDOC, like its endometrial counterpart, is highly aggressive and is characterized by frequent inactivation of core SWI/SNF complex proteins and MMR deficiency. Its molecular profile overlaps with UDEC while being distinct from SCCOHT and HGSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCarcinomaEndometrial NeoplasmsCarcinoma, Small CellBrain NeoplasmsNeoplastic Syndromes, HereditaryColorectal NeoplasmsFemaleHumansMiddle AgedYoung AdultAdultAgedTumor Suppressor Protein p53DNA Copy Number VariationsCarcinoma, Ovarian EpithelialBiomarkers, TumorDNA HelicasesNuclear ProteinsTranscription Factors

Stichwörter der Autor:innen

ARID1BSMARCA4SMARCB1SWI/SNFmethylationundifferentiated ovarian carcinoma

Substanzen

Tumor Suppressor Protein p53Biomarkers, TumorSMARCA4 protein, humanDNA HelicasesNuclear ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
  • Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, Canada.
  • Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, British Columbia, Canada.

Förderung

  • WCHRI
  • Alberta Cancer Foundation
  • Children's Health Research Institute
  • University of Alberta

Zitieren

APA

Tessier-Cloutier, B., Kommoss, F. K. F., Kolin, D. L., Němejcová, K., Smith, D., Pors, J., Stewart, C. J. R., McCluggage, W. G., Foulkes, W. D., von Deimling, A., Köbel, M., & Lee, C. H. (2024). Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation. Modern Pathology, 37(1), 100374. https://doi.org/10.1016/j.modpat.2023.100374

Vancouver

Tessier-Cloutier B, Kommoss FKF, Kolin DL, Němejcová K, Smith D, Pors J, et al. Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation. Modern Pathology. 2024;37(1):100374. doi:10.1016/j.modpat.2023.100374

BibTeX
@article{TessierCloutier2024,
  author = {Tessier-Cloutier, Basile and Kommoss, Felix K F and Kolin, David L and Němejcová, Kristýna and Smith, DuPreez and Pors, Jennifer and Stewart, Colin J R and McCluggage, W Glenn and Foulkes, William D and von Deimling, Andreas and Köbel, Martin and Lee, Cheng-Han},
  title = {Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {1},
  pages = {100374},
  doi = {10.1016/j.modpat.2023.100374}
}
Kostenlos starten →